Article
Ocular Gene Therapy: An Overview of Viral Vectors, Immune Responses, and Future Directions
19 Dec 2024
Abstract excerpt
Ocular gene therapy has rapidly advanced from proof-of-concept studies to clinical trials by exploiting the unique advantages of the eye, including its easy accessibility, relative immune privilege, and the ability to use the contralateral eye as a control. An important step forward was achieved with the Food and Drug Administration (FDA) approval of voretigene neparvovec (Luxturna) for the treatment of biallelic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
